Arrhythmia in COVID-19.

• Type of Material: Article
• Authors: Savalan Babapoor-Farrokhran, Einstein Medical Center; Roozbeh Rasekhi, Emory University; Deanna Gill, Emory University; Shaghayegh Babapoor, Sina Hospital; Aman Amanullah, Thomas Jefferson University
• Language: English
• Date: 2020-08-14
• Publisher: Springer
• Publication Version: Final Published Version
• Copyright Statement: © Springer Nature Switzerland AG 2020.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1007/s42399-020-00454-2
• Title of Journal or Parent Work: SN Comprehensive Clinical Medicine
• Volume: 2
• Start Page: 1
• End Page: 6
• Grant/Funding Information: None declared
• Keywords: Sinus tachycardia; Severe acute respiratory syndrome; Ventricular tachycardia; Middle east respiratory syndrome; Atrial fibrillation; QT prolongation; Arrhythmias; Torsade de pointes; Ventricular fibrillation; Coronavirus disease 2019; Ventricular arrhythmias; Sinus bradycardia; Viral infection
• Research Categories: Health Sciences, Epidemiology; Health Sciences, Radiology; Biology, Virology; Health Sciences, Public Health

Abstract

The current outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) also known as coronavirus disease 2019 (COVID-19) has quickly progressed to a global pandemic. There are well-documented cardiac complications of COVID-19 in patients with and without prior cardiovascular disease. The cardiac complications include myocarditis, heart failure, and acute coronary syndrome resulting from coronary artery thrombosis or SARS-CoV-2-related plaque ruptures. There is growing evidence showing that arrhythmias are also one of the major complications. Myocardial inflammation caused by viral infection leads to electrophysiological and structural remodeling as a possible mechanism for arrhythmia. This could also be the mechanism through which SARS-CoV-2 leads to different arrhythmias. In this review article, we discuss arrhythmia manifestations in COVID-19.